PEN: Penumbra Inc

PEN新闻

• 13:04 Penumbra Wins FDA Clearance For Lightning CAVT Technology To Treat Deep Vein Thrombosis, Backed By BOLT-DVT Trial Results
• 17:27 AngioDynamics: Progress Evident, But Volatility And Margin Concerns Persist (NASDAQ:ANGO)
• 13:12 Penumbra Presents Results From Subset Analysis Of STORM-PE Randomized Controlled Trial At Vascular InterVentional Advances Meeting
• 14:40 IART vs. PEN: Which Stock Is the Better Value Option?
• 14:40 IART or PEN: Which Is the Better Value Stock Right Now?
• 09:02 Boston Scientific: Market Pessimism Has Pushed The Stock Into Undervalued Territory (NYSE:BSX)
• 16:37 Is Zimmer Biomet Stock Underperforming the Nasdaq?
• 13:13 Reasons to Retain Penumbra Stock in Your Portfolio for Now
• 15:40 TFX vs. PEN: Which Stock Is the Better Value Option?
• 15:40 TFX or PEN: Which Is the Better Value Stock Right Now?
• 15:40 TFX vs. PEN: Which Stock Is the Better Value Option?
• 18:16 Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
• 15:07 AngioDynamics: Growth Is Working, Price Knows It (Downgrade) (NASDAQ:ANGO)
• 15:40 IQV vs. PEN: Which Stock Is the Better Value Option?
• 05:15 Tactile Systems Stock: Clean Balance Sheet, But A Possible Value Trap (NASDAQ:TCMD)
• 15:59 Boston Scientific: The Time Has Come To Catch This Falling Knife (NYSE:BSX)
• 15:40 GMED vs. PEN: Which Stock Should Value Investors Buy Now?
• 16:47 Penumbra Receives CE Nod for THUNDERBOLT: Stock to Gain?
• 10:36 ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
• 15:40 GMED or PEN: Which Is the Better Value Stock Right Now?
• 15:30 Why Is Penumbra (PEN) Down 1.2% Since Last Earnings Report?
• 19:16 Baron Health Care Fund Q1 2026 Portfolio Activity
• 03:25 Diamond Hill Long-Short Strategy Q1 2026 Portfolio Movers: Gains, Drags, And Trades
• 21:25 Penumbra (PEN) Misses Q1 Earnings Estimates